Docetaxel nanotechnology in anticancer therapy (Q38003964)

26 August 2017

Docetaxel nanotechnology in anticancer therapy (English)

1 reference

26 August 2017

0 references

1 reference

2

Didier Astruc

1 reference

26 August 2017

Pengxiang Zhao

1

1 reference

26 August 2017

19 April 2012

1 reference

26 August 2017

1 reference

26 August 2017

7

1 reference

26 August 2017

6

1 reference

26 August 2017

952-972

1 reference

A systematic review of viral infections associated with oral involvement in cancer patients: a spotlight on Herpesviridea

26 August 2017

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201200052

Classification of anticancer drugs—a new system based on therapeutic targets

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201200052

Natural taxanes: developments since 1828.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201200052

Relationships between the structure of taxol analogs and their antimitotic activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201200052

Relationships between the structures of taxol and baccatine III derivatives and their in vitro action on the disassembly of mammalian brain and Physarum amoebal microtubules

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201200052

Albumin-bound paclitaxel: the benefit of this new formulation in the treatment of various cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201200052

Targeted delivery for breast cancer therapy: the history of nanoparticle-albumin-bound paclitaxel

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201200052

Comparison of active and passive targeting of docetaxel for prostate cancer therapy by HPMA copolymer-RGDfK conjugates.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201200052

Encapsulation of docetaxel in oily core polyester nanocapsules intended for breast cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201200052

Docetaxel and Cisplatin Plus Fluorouracil compared with Modified Docetaxel, Cisplatin, and 5-Fluorouracil as first-line therapy for advanced gastric cancer: a retrospective analysis of single institution

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201200052

Phase II study of docetaxel weekly in combination with carboplatin every 3 weeks as first-line chemotherapy in stage IIB to stage IV epithelial ovarian cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201200052

MR-guided pulsed high intensity focused ultrasound enhancement of docetaxel combined with radiotherapy for prostate cancer treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201200052

Phase II Study of S-1 Plus Either Irinotecan or Docetaxel for Non-small Cell Lung Cancer Patients Treated with More Than Three Lines of Treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201200052

Clinical pharmacokinetics of docetaxel.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201200052

Role of formulation vehicles in taxane pharmacology

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201200052

Novel docetaxel-loaded nanoparticles based on poly(lactide-co-caprolactone) and poly(lactide-co-glycolide-co-caprolactone) for prostate cancer treatment: formulation, characterization, and cytotoxicity studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201200052

Docetaxel: a review of its use in metastatic breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201200052

Improved biochemical strategies for targeted delivery of taxoids

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201200052

Docetaxel and paclitaxel in the treatment of breast cancer: a review of clinical experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201200052

Nanocarriers as an emerging platform for cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201200052

Receptor mediated tumor targeting: an emerging approach for cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201200052

Active targeting schemes for nanoparticle systems in cancer therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201200052

Nanoparticles for drug delivery in cancer treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201200052

Imparting size, shape, and composition control of materials for nanomedicine

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201200052

Optimizing saccharide-directed molecular delivery to biological receptors: design, synthesis, and biological evaluation of glycodendrimer-cyclodextrin conjugates

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201200052

Dendrimers in drug research

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201200052

Dendrimers for enhanced drug solubilization.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201200052

Drug delivery using nanoparticle-stabilized nanocapsules.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201200052

In vivo delivery of silica nanorattle encapsulated docetaxel for liver cancer therapy with low toxicity and high efficacy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201200052

Poly(ethylene glycol)-b-poly(epsilon-caprolactone) micelles containing chemically conjugated and physically entrapped docetaxel: synthesis, characterization, and the influence of the drug on micelle morphology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201200052

Poly(lactide)-vitamin E derivative/montmorillonite nanoparticle formulations for the oral delivery of Docetaxel

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201200052

Preparation and characterization of taxane-containing liposomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201200052

Amphipathic polyethyleneglycols effectively prolong the circulation time of liposomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201200052

Highly efficient system to deliver taxanes into tumor cells: docetaxel-loaded chitosan oligomer colloidal carriers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201200052

Steroid hormone receptors in breast cancer management

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201200052

Receptor-targeted nanocarriers for therapeutic delivery to cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201200052

Advances in polymeric micelles for drug delivery and tumor targeting

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201200052

A peptide-targeted delivery system with pH-sensitive amphiphilic cell membrane disruption for efficient receptor-mediated siRNA delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201200052

In vitro comparative evaluation of trastuzumab (Herceptin) combined with paclitaxel (Taxol) or docetaxel (Taxotere) in HER2-expressing human breast cancer cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201200052

A monoclonal antibody that binds anionic phospholipids on tumor blood vessels enhances the antitumor effect of docetaxel on human breast tumors in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201200052

Monoclonal antibody targeting MUC1 and increasing sensitivity to docetaxel as a novel strategy in treating human epithelial ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201200052

Tumor specific delivery and therapy by double-targeted nanostructured lipid carriers with anti-VEGFR-2 antibody

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201200052

Dietary polyunsaturated fatty acids and cancers of the breast and colorectum: emerging evidence for their role as risk modifiers

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201200052

Multi-drug loaded polymeric micelles for simultaneous delivery of poorly soluble anticancer drugs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201200052

Nanoparticles for drug delivery prepared from amphiphilic PLGA zwitterionic block copolymers with sharp contrast in polarity between two blocks

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201200052

HPMA copolymer conjugates of paclitaxel and docetaxel with pH-controlled drug release

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201200052

Potent engineered PLGA nanoparticles by virtue of exceptionally high chemotherapeutic loadings

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201200052

Drug delivery systems: entering the mainstream

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201200052

Dendrimers designed for functions: from physical, photophysical, and supramolecular properties to applications in sensing, catalysis, molecular electronics, photonics, and nanomedicine

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201200052

Sterically stabilized liposomes: a hypothesis on the molecular origin of the extended circulation times

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201200052

Targetable HPMA copolymer-adriamycin conjugates. Recognition, internalization, and subcellular fate.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201200052

Structure and design of polymeric surfactant-based drug delivery systems

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201200052

NGR-modified micelles enhance their interaction with CD13-overexpressing tumor and endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201200052

Docetaxel loaded oleic acid-coated hydroxyapatite nanoparticles enhance the docetaxel-induced apoptosis through activation of caspase-2 in androgen independent prostate cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201200052

Opsonization, biodistribution, cellular uptake and apoptosis study of PEGylated PBCA nanoparticle as potential drug delivery carrier

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201200052

Biodegradation and biocompatibility of PLA and PLGA microspheres

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201200052

Chitosan and its use as a pharmaceutical excipient

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201200052

Chitosan and its derivatives as intestinal absorption enhancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201200052

Potential applications of chitosan in veterinary medicine

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201200052

Fluorescent nanoparticles of chitosan complex for real-time monitoring drug release.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201200052

Novel polymer micelles prepared from chitosan grafted hydrophobic palmitoyl groups for drug delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201200052

Formation and properties of chitosan-cellulose nanocrystal polyelectrolyte-macroion complexes for drug delivery applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201200052

Biodegradation, biodistribution and toxicity of chitosan

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201200052

Design and evaluation of cyclodextrin-based drug formulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201200052

Skin permeation study of dehydroepiandrosterone (DHEA) compared with its alpha-cyclodextrin complex form

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201200052

In Vitro Gene Delivery Mediated by Asialofetuin-Appended Cationic Liposomes Associated with γ-Cyclodextrin into Hepatocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201200052

Polypseudorotaxanes of pegylated insulin with cyclodextrins: application to sustained release system

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201200052

Conjugated chitosan as a novel platform for oral delivery of paclitaxel

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201200052

In vivo antitumor effects of chitosan-conjugated docetaxel after oral administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201200052

Tumor targetability and antitumor effect of docetaxel-loaded hydrophobically modified glycol chitosan nanoparticles

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201200052

Cyclodextrins in topical drug formulations: theory and practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201200052

Porphyrin-cyclodextrin conjugates as a nanosystem for versatile drug delivery and multimodal cancer therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201200052

In vitro modulation of doxorubicin and docetaxel antitumoral activity by methyl-beta-cyclodextrin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201200052

The intracellular effects of non-ionic amphiphilic cyclodextrin nanoparticles in the delivery of anticancer drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201200052

Nanoparticles in cancer therapy and diagnosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201200052

The Bakerian Lecture: Experimental Relations of Gold (and Other Metals) to Light

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201200052

Gold nanoparticles: assembly, supramolecular chemistry, quantum-size-related properties, and applications toward biology, catalysis, and nanotechnology

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201200052

Cellular uptake and toxicity of Au55 clusters

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201200052

Biological properties of "naked" metal nanoparticles

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201200052

Gold nanoparticle platforms as drug and biomacromolecule delivery systems

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201200052

Self-assembled monolayers of thiolates on metals as a form of nanotechnology

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201200052

In vitro release behavior and cytotoxicity of doxorubicin-loaded gold nanoparticles in cancerous cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201200052

Encapsulation of docetaxel into PEGylated gold nanoparticles for vectorization to cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201200052

Cellular uptake and cytotoxicity of silica nanotubes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201200052

Photocontrolled reversible release of guest molecules from coumarin-modified mesoporous silica.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201200052

A mesoporous silica nanosphere-based carrier system with chemically removable CdS nanoparticle caps for stimuli-responsive controlled release of neurotransmitters and drug molecules.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201200052

Mesoporous silica nanoparticles as a delivery system for hydrophobic anticancer drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201200052

Co-delivery of doxorubicin and Bcl-2 siRNA by mesoporous silica nanoparticles enhances the efficacy of chemotherapy in multidrug-resistant cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201200052

Selective accumulation and growth inhibition of hybrid liposomes to human hepatocellular carcinoma cells in relation to fluidity of plasma membranes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201200052

Targeted delivery of a novel palmitylated D-peptide for antiglioblastoma molecular therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201200052

Fluorescence signal enhancement of polydiacetylene vesicle stacks.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201200052

Micro-total analysis system for virus detection: microfluidic pre-concentration coupled to liposome-based detection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201200052

Noncovalent liposome linkage and miniaturization of capsosomes for drug delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201200052

Impact of nanotechnology on drug delivery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201200052

Self-assembled lipid--polymer hybrid nanoparticles: a robust drug delivery platform.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201200052

Recent advances with liposomes as pharmaceutical carriers

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201200052

Phase II Trial Of Pegylated-liposomal Doxorubicin (Doxil™) In Sarcoma*

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201200052

Nanoparticles in medicine: therapeutic applications and developments

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201200052

A monolayer study on interactions of docetaxel with model lipid membranes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201200052

Preparation, characterization and pharmacokinetics of folate receptor-targeted liposomes for docetaxel delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201200052

Folate-targeted polymeric nanoparticle formulation of docetaxel is an effective molecularly targeted radiosensitizer with efficacy dependent on the timing of radiotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201200052

Targeted nanoassembly loaded with docetaxel improves intracellular drug delivery and efficacy in murine breast cancer model

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201200052

Effects of emulsifiers on the controlled release of paclitaxel (Taxol) from nanospheres of biodegradable polymers

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201200052

Antitumor effect of paclitaxel-loaded PEGylated immunoliposomes against human breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201200052

Overcoming the formulation obstacles towards targeted chemotherapy: in vitro and in vivo evaluation of cytotoxic drug loaded immunonanoparticles

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201200052

Evaluation of docetaxel-loaded intravenous lipid emulsion: pharmacokinetics, tissue distribution, antitumor activity, safety and toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201200052

The effect of particle design on cellular internalization pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201200052

Cancer nanotechnology: opportunities and challenges

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201200052

Sustained antibacterial activity of doxycycline-loaded poly(D,L-lactide-co-glycolide) and poly(epsilon-caprolactone) nanoparticles

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201200052

Alpha v integrins as receptors for tumor targeting by circulating ligands.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201200052

Phage libraries displaying cyclic peptides with different ring sizes: ligand specificities of the RGD-directed integrins

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201200052

Targeting of RGD-modified proteins to tumor vasculature: a pharmacokinetic and cellular distribution study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201200052

Liposomes modified with cyclic RGD peptide for tumor targeting

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201200052

Pharmacokinetics and tumor retention of 125I-labeled RGD peptide are improved by PEGylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201200052

Folic acid conjugated nanoparticles of mixed lipid monolayer shell and biodegradable polymer core for targeted delivery of Docetaxel

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201200052

The over-expression of HAS2, Hyal-2 and CD44 is implicated in the invasiveness of breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201200052

Differential expression of CD44 in canine melanocytic tumours.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201200052

Novel hyaluronic acid (HA) coated drug carriers (HCDCs) for human breast cancer treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201200052

Self-assembled nanoparticles based on hyaluronic acid-ceramide (HA-CE) and Pluronic® for tumor-targeted delivery of docetaxel

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201200052

Antineoplastic drugs that interfere with iron metabolism in cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201200052

Nanotherapeutics to overcome conventional cancer chemotherapy limitations

21 January 2018

2 references

https://api.crossref.org/works/10.1002%2FCMDC.201200052

21 January 2018

https://api.crossref.org/works/10.1002%2FCMDC.201200052

7 January 2021

Transferrin-conjugated nanoparticles of poly(lactide)-D-alpha-tocopheryl polyethylene glycol succinate diblock copolymer for targeted drug delivery across the blood-brain barrier

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201200052

Phase I clinical trial of liposomal-encapsulated doxorubicin citrate and docetaxel, associated with trastuzumab, as neo-adjuvant treatment in stages II and IIIA, HER2-overexpressing breast cancer patients. GEICAM 2003-03 study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201200052

Cetuximab in combination with carboplatin and docetaxel for patients with metastatic or advanced-stage nonsmall cell lung cancer: a multicenter phase 2 study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201200052

Phase II study of efficacy and safety of bevacizumab in combination with chemotherapy or erlotinib compared with chemotherapy alone for treatment of recurrent or refractory non small-cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201200052

Tumor growth modeling from clinical trials reveals synergistic anticancer effect of the capecitabine and docetaxel combination in metastatic breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201200052

Mesoporous silica nanoparticles as controlled release drug delivery and gene transfection carriers

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201200052

Nanoparticles: scaffolds for molecular recognition

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201200052

Gold nanoparticles in biology: beyond toxicity to cellular imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201200052

Nanoshell-enabled photothermal cancer therapy: impending clinical impact

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201200052

Gold nanoparticles in nanomedicine: preparations, imaging, diagnostics, therapies and toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201200052

Applications of vectorized gold nanoparticles to the diagnosis and therapy of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201200052

Theranostic nanoshells: from probe design to imaging and treatment of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201200052

Preparation, characterization, cytotoxicity and pharmacokinetics of liposomes containing docetaxel

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201200052

The antitumor effect of novel docetaxel-loaded thermosensitive micelles

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201200052

PLA/PLGA nanoparticles for sustained release of docetaxel.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201200052

Cancer nanotheranostics: improving imaging and therapy by targeted delivery across biological barriers

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201200052

Preclinical and clinical studies of NK012, an SN-38-incorporating polymeric micelles, which is designed based on EPR effect

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201200052

Cancer theranostics with near-infrared light-activatable multimodal nanoparticles

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201200052

Nanomedicine for targeted cancer therapy: towards the overcoming of drug resistance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201200052

Au nanoparticles target cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201200052

Targeted Intracellular Delivery of Hydrophobic Agents using Mesoporous Hybrid Silica Nanoparticles as Carrier Systems

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201200052

[Targeting for drug delivery and imaging: an overview of the state of the art in cancer]

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201200052

7 January 2021

Taxoids: new weapons against cancer

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201200052

7 January 2021

Tumor-Specific Novel Taxoid−Monoclonal Antibody Conjugates

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201200052

7 January 2021

Nanotechnology. Nanoparticle Trojan horses gallop from the lab into the clinic

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201200052

7 January 2021

Preclinical pharmacokinetic, biodistribution, and anti-cancer efficacy studies of a docetaxel-carboxymethylcellulose nanoparticle in mouse models

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201200052

7 January 2021

Polymeric systems for controlled drug release

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201200052

7 January 2021

Therapeutic effects of leuprorelin microspheres on endometriosis and uterine leiomyomata

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201200052

7 January 2021

Modeling of Drug (Albumin) Release from Thermosensitive Chitosan Hydrogels

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201200052

7 January 2021

Improvement of some physicochemical properties of arundic acid, (R)-(-)-2-propyloctanonic acid, by complexation with hydrophilic cyclodextrins

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201200052

7 January 2021

Reduction of bitterness of antihistaminic drugs by complexation with β-cyclodextrins

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201200052

7 January 2021

Cyclodextrin Drug Carrier Systems

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201200052

7 January 2021

Mesoporous silica nanoparticles deliver DNA and chemicals into plants

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201200052

7 January 2021

Preparation and characterization of a submicron lipid emulsion of docetaxel: submicron lipid emulsion of docetaxel

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201200052

7 January 2021

Identifiers

DOI

10.1002/CMDC.201200052

1 reference

26 August 2017

1 reference

PubMed ID

22517723